Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Variations in New Clinical Trial Designs for Emerging CEP Devices

Presentation TCT 2024

Variations in New Clinical Trial Designs for Emerging CEP Devices

Presenter: Alexandra Lansky

October 30, 2024

Novel Technologies in CEP During TAVR: Emboliner, ProTembo, Emblok, Filterex, and Others

Presentation TCT 2024

Novel Technologies in CEP During TAVR: Emboliner, ProTembo, Emblok, Filterex, and Others

Presenter: Tamim Nazif

October 30, 2024

Primary Endpoint Results with the Second-Generation Cephea Transseptal TMVR System in Complex Mitral Valve Disease

Presentation TCT 2024

Primary Endpoint Results with the Second-Generation Cephea Transseptal TMVR System in Complex Mitral Valve Disease

Presenter: Pradeep Yadav

October 29, 2024

Case: Evolving Stroke After TAVR

Presentation TCT 2024

Case: Evolving Stroke After TAVR

Presenter: Jason Bloom

October 28, 2024

Incidence, Diagnosis, and Management of Evolving Strokes After TAVR

Presentation TCT 2024

Incidence, Diagnosis, and Management of Evolving Strokes After TAVR

Presenter: Julia Seeger

October 28, 2024

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

Presentation TCT 2024

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

Presenter: Aakriti Gupta

October 28, 2024

CEP Technology Landscape and Study Design

Presentation TCT 2024

CEP Technology Landscape and Study Design

Presenter: Mathew Williams

October 28, 2024

Presentation NY Valves 2024

Cephea

Presenter: Juan F. Granada

June 06, 2024

Evaluation of the Role of SENTINEL CEPD in Reducing the Risk of Stroke From TAVR in Patients With Bicuspid Aortic Valve Stenosis

Presentation NY Valves 2024

Evaluation of the Role of SENTINEL CEPD in Reducing the Risk of Stroke From TAVR in Patients With Bicuspid Aortic Valve Stenosis

Presenter: Sukhdeep Singh Basra

June 06, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.